We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Please watch the video for more information
days to go: Expired investment: £376,618
StarStock are a drinks marketplace that enable suppliers to sell direct to wholesalers, pubs, shops, bars & restaurants nationwide. StarStock puts the suppliers in control of their products and listings, taking a small percentage of each sale. Suppliers set the prices, while we do the rest, arranging delivery of beers, ciders, wine and spirits.
days to go: Expired investment: £1,343,149
Crowd Cook was built to help Britains talented amateur cooks show the world just how good they really are and to supply retailers with extraordinary food from the crowd. 
days to go: Expired investment: £28,560
Feast is a late night delivery service working with over 80 hotels and have served 20k customers to date. They work with some of the best 24-hour restaurants and deliver to customers and partner hotels between the hours of 7pm and 5am.
days to go: Expired investment: £152,570
Premium popsicles partnered with Pimm's producers and available as alcohol and alcohol-free. POPS has pioneered a contemporary and innovative concept within the ice cream industry. Since inception, their business and product range has grown and now consist of popsicles made from real fruit, all natural ingredients and are less than 60 calories. One of their most notable products is the champagne ice popsicle, a world first. POPS have generated sales of more than £590k in the first half of 2018, which is equivalent to their total sales in 2017. Their products are available at major retailers, including Ocado and Tesco. As well as regional locations, such as Spar, Musgraves, Whole Foods and 500 other independent stockists. The range is also sold at festivals, sporting events, cinemas, theatres and leisure groups. Funds are being raised to launch new product ranges in 2019 that are aimed at a wider target audience and suitable in most situations. POPS aims to ensure their products meet consumer trends in regards to health and portion sizes.
days to go: Expired investment: £479,550
QuickQueue enables users to order-ahead for food & drinks in quick-service restaurants - with orders paid-for, ready to collect upon arrival and loyalty points automatically saved on their phone. With QuickQueue, users save time and money, while retailers increase profits by intensifying customer loyalty and gaining unparalleled customer analytics.
days to go: Expired investment: £283,124
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph